N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine Dihydrochloride

CAS : 168266-51-1

Ref. 3D-FM102827

Informations sur le produit

• Nom: N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine Dihydrochloride
• Synonymes: 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoro-methyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S,3S)-, 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S-cis)-, Gr 205171A, GR 205171 Dihydrochloride, N-{2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]benzyl}-2-phenylpiperidin-3-amine dihydrochloride

Description

N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine Dihydrochloride is a drug that belongs to the group of antimuscarinic drugs. It may be used as an adjuvant therapy for chronic kidney disease and to treat bowel diseases, including inflammatory bowel disease. NMPPD inhibits the activity of adenosine receptors in the central nervous system and peripheral tissues. This drug has been shown to decrease the levels of growth factors in the body, such as epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF), and it has also been found to have antidepressant properties. NMPPD is also a cancer chemotherapeutic agent that acts by inhibiting the production of neurokinin 1 receptor ligands, which are involved in cell proliferation

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 505.36 g/mol
• Formule: C₂₁H₂₅Cl₂F₃N₆O
• Degré de pureté: Min. 95%